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Abstract
We have investigated the mechanism of lipoplex-mediated transfection, employing a dialkyl pyridinium surfactant
(SAINT-2), and using serum as a modulator of complex stability and processing. Particle size and stability determine lipoplex
internalization, the kinetics of intracellular processing, and transfection efficiency. Clustered SAINT-2 lipoplexes are
obtained in the absence of serum (3FBS lipoplexes), but not in its presence (+FBS lipoplexes), or when serum was present
during lipoplex formation [FBS], conditions that mimic potential penetration of serum proteins. The topology of DNA in
[FBS] lipoplexes shifts from a supercoiled, as in 3FBS lipoplexes, to a predominantly open-circular conformation, and is
more prone to digestion by DNase. Consistently, atomic force microscopy revealed complexes with tubular extensions,
reflecting DNA that protrudes from the lipoplex surface. Interestingly, the internalization of [FBS] lipoplexes is
approximately three-fold higher than that of 3FBS and +FBS lipoplexes, yet their transfection efficiency is approximately
five-fold lower. Moreover, in contrast to 3FBS and +FBS complexes, [FBS] complexes were rapidly processed into the late
endosomal/lysosomal degradation pathway. Intriguingly, transfection by [FBS] complexes is greatly improved by osmotic
rupture of endocytic compartments. Our data imply that constraints in size and morphology govern the complex’ ability to
interact with and perturb cellular membranes, required for gene release. By extrapolation, we propose that serum may
regulate these parameters in an amphiphile-dependent manner, by complex ‘penetration’ and modulation of DNA
conformation. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The use of viral vectors for delivery of therapeutic
genetic material into somatic cells (gene therapy) has
several important drawbacks, including the risk of
immunogenicity, potential recombination with en-
dogenous viruses and cytotoxicity. Promising non-
viral gene carriers are those that are based upon
the use of cationic lipids. Because of their positive
charge they spontaneously associate with negatively
charged nucleic acids, thereby forming lipoplexes [1^
3]. However, to match viral vectors, further improve-
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ment of their e⁄ciency of delivery and gene expres-
sion is needed. This implies the need for further fun-
damental insight into the mechanism of amphiphile-
mediated delivery, particularly in light of observa-
tions that the transfection e⁄ciency of numerous cat-
ionic lipid formulations is reduced in the presence of
serum. Speci¢cally, a better understanding of lipo-
plex structure and stability is needed to clarify pa-
rameters that govern the mechanism of lipofection,
thus providing tools for improving gene delivery.
Endocytosis is thought to represent a major entry
pathway for productive transfection [4,5]. Szoka et
al. [6] proposed a model for the destabilization of the
complex and release of DNA into the cell’s cyto-
plasm, a step which appears necessary for nuclear
uptake and subsequent transcription of the exoge-
nous DNA [4]. The involvement of endocytosis and
lipoplex-mediated membrane destabilization in the
transfection process necessarily imply that lipoplex
size and stability, presumably dictated in part by
the chemical nature of the amphiphile employed,
should be important parameters in governing trans-
fection e⁄ciency, since the endocytic internalization
capacity of cells, involving either coated or non-
coated mechanisms, is restricted by particle size. Fur-
thermore, once internalized, the complex should per-
turb the endosomal boundary and dissociate to allow
the gene to acquire access to the nuclear transcrip-
tion machinery.
In vitro, a reduced transfection e⁄ciency is often
been observed in the presence of serum [7^10]. In
fact, serum may strongly interfere with lipoplex
size, by preventing particle clustering, and a¡ect par-
ticle stability. When assuming complex internaliza-
tion to be required for cellular transfection, it would
a priori be anticipated that smaller particles are more
e⁄ciently processed by cells and bring about trans-
fection than larger complexes, which arise in the ab-
sence of serum. However, in spite of the enhanced
size in the absence of serum, transfection at such
conditions is often highly e⁄cient, implying that fac-
tors other than size per se play a decisive role in
determining e⁄ciency. Indeed, it has been suggested
that binding of serum proteins to the lipoplex pre-
vents its interaction with the cell surface and/or its
internalization, thereby inhibiting transfection
[2,11,12]. However, no proportional correlation has
been found between the cellular uptake of lipoplexes
and their transfection e⁄ciency [13,14]. Accordingly,
given the need for intracellular release of plasmids as
a crucial step in overall transfection, serum may also
a¡ect the stability of the particle [11,15], thus inter-
fering with the cytosolic release and dissociation of
the complex, following endocytic internalization [16].
However, little insight is available in these events at
both the cellular and molecular level.
Recently, we synthesized a dialkyl pyridinium cat-
ionic amphiphile, SAINT-2, which e⁄ciently trans-
fects cells in vitro [17]. The size of the complex par-
ticles appears sensitive to serum, but the transfection
e⁄ciency is not [14,18]. In the present work we have
examined the e¡ect of serum on particle size and
stability of SAINT/DOPE-DNA complexes, and ex-
amined the consequences in terms of lipoplex^cell
interaction. The data lead us to propose that particle
size and/or morphology govern the intracellular pro-
cessing of lipoplexes in the endocytic pathway,
(smaller) serum protein-‘penetrated’ particles being
delivered to lysosomes prior to their ability to release
their cargo from pre-lysosomal endocytic compart-
ments. Transfection e⁄ciency is thus determined by
the stability of the complex, which can be regulated
by the amphiphile-dependent nature of the interac-
tion of serum proteins with such complexes.
2. Materials and methods
2.1. Preparation of liposomes and lipoplexes
A methanolic solution of SAINT-2, synthesized as
described elsewhere [17], and DOPE (Avanti Polar
Lipids, Alabaster, AL, USA) (1:1) was dried under
a stream of nitrogen. The residual solvent was re-
moved under vacuum. The lipid ¢lm was dissolved
in Millipore water (lipid concentration: 1 mM) and
sonicated to clarity in a bath sonicator. Liposomes
(170 nm) and pDNA (pEGFP-N1, Clontech, Palo
Alto, CA, USA) were taken up in equal volumes
(0.5 ml) of serum-free cell culture medium and im-
mediately mixed in a 2.5:1 molar charge ratio (15
nmol lipid; 1 Wg DNA) by rapidly pipetting DNA
to the liposome suspension. Lipoplexes (3FBS) were
allowed to form for 10 min at room temperature
before addition of serum in the case of transfection
in the presence of serum (+FBS). Subsequently, lipo-
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plexes were added to the cell culture. Alternatively,
lipoplexes were also prepared in the presence of 10%
serum, using serum-containing cell culture medium
and following the same procedure as mentioned
above. These particles are de¢ned as [FBS] lipo-
plexes.
To examine the cellular fate of the complex by
£uorescence microscopy, rhodamine-labeled lipo-
plexes were made by adding 0.5 mol% N-rhod-
amine-PE (Avanti Polar Lipids) to the initial
SAINT-2/DOPE (1:1) solution. To examine the cel-
lular association of lipoplexes radioactively labeled
SAINT-2 was synthesized. For this purpose, the am-
monium head group of the pyridine compound was
quaternized using 14C-labeled methyl iodide (Amer-
sham, Amersham, UK).
2.2. Atomic force microscopy of lipoplexes
3FBS, +FBS, and [FBS] lipoplexes were prepared
as described and after 1 h they were directly trans-
ferred onto a silicon chip by dipping the chip into the
lipoplex solution. Atomic force microscopy was per-
formed on a Digital Nanoscope IIIa Dimension 5000
(Digital Instruments, Santa Barbara, CA, USA) as
described elsewhere [19]. The microscope was vibra-
tion-damped. Commercial pyramidal Si3N4 tips
(NCH-W, Digital Instruments) on a cantilever with
a length of 125 Wm were used. The resonance fre-
quency was about 220 kHz, and the nominal force
constant was 36 N/m. All measurements were per-
formed in Tapping mode to prevent damage of the
sample surface. The scan speed was proportional to
the scan size and the scan frequency was between 0.5
and 1.5 Hz. Images were obtained by displaying the
amplitude signal of the cantilever in the trace direc-
tion, and the height signal in the retrace direction,
both signals being simultaneously recorded. The re-
sults were visualized either in height or in amplitude
modus.
2.3. Dextran density gradient of lipoplexes
Discontinuous dextran gradients were prepared as
described by Eastman et al. [20], with some slight
modi¢cations. In brief, a stock solution of 30%
(w/v) dextran T-500 (Amersham Pharmacia Biotech
AB, Sweden), containing 5 Wg/ml ethidium bromide
(EtBr) was made in HBSS (Gibco, The Netherlands).
Dilutions to 20%, 15%, 10% and 5% dextran were
made with HBSS containing 5 Wg/ml EtBr. 2 ml of
each dextran dilution (30^5%) was layered in a cen-
trifuge tube (Beckmann Ultraclear; 14U89 mm).
Complexes, labeled with 5 mol% N-Rh-PE, were pre-
pared in 1 ml HBSS and layered on top of the gra-
dient. After addition of 1 ml HBSS containing 5 Wg/
ml EtBr, the gradients were centrifuged for 1 h (4‡C)
at 36 000 rpm. Photographs were taken using a Po-
laroid camera with normal light to visualize the lipids
and UV light to visualize the DNA.
2.4. Agarose gel electrophoresis of lipoplexes
3FBS lipoplexes, +FBS lipoplexes, and [FBS]
lipoplexes were suspended in HBSS (Gibco) and in-
cubated for 10 min at 37‡C, followed by treatment
with DNase (1/2 h; 37‡C) and/or Zwittergent (Cal-
biochem, San Diego, CA, USA), and loaded (in 30%
glycerol) on a 0.8% agarose gel containing 1.25 WM
EtBr. +FBS and [FBS] lipoplexes were treated with
Zwittergent after proteinase K digestion (3.2 mg/ml).
The latter was done to prevent the interaction of
serum proteins with DNA after the release of DNA
from the lipoplexes. Control experiments were car-
ried out to verify the in£uence of the presence of
serum proteins (10 and 50% FBS) as well as protein-
ase K on DNA conformation. Incubation of DNA
with DNase for 1/2 h at 37‡C resulted in a complete
degradation of DNA (not shown). A current of 40
mA (80 V) was applied over the gel, immersed in 0.5
mM TBE bu¡er (0.045 M Tris^borate/0.001 M
EDTA). The agarose gels were photographed with
a Polaroid camera.
2.5. Transfection of COS-7 cells with SAINT-2/
DOPE lipoplexes
1 day before transfection, COS-7 cells were plated
in a 12-well plate (Costar, 1.3U105 cells/well). Prior
to addition of the various lipoplexes, the cells were
washed twice with HBSS (Gibco). Then 0.5 ml of the
lipoplex mixtures, 3FBS, +FBS or [FBS], prepared
as described in Section 2.1 were added to the cells,
and incubated at 37‡C/5% CO2. After 4 h the trans-
fection medium was replaced by cell culture medium
(DMEM; Gibco), containing 7% fetal bovine serum
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(FBS), 2 mM L-glutamine (Gibco), 100 units/ml pen-
icillin (Gist-Brocades, The Netherlands), 100 mg/ml
streptomycin (Biochemie, Austria). After 24 h the
cells were screened for reporter gene (green £uores-
cent protein) expression by FACS (Elite, Coulter; Vex
488 nm, Vem 530 nm; 5000 events).
The cellular fate of the lipoplexes was examined by
£uorescence microscopy (Olympus AX70 equipped
with an Olympus PM-20 photography system).
For determination of the kinetics of lipoplex inter-
nalization by COS-7 cells, 14C-labeled SAINT-2 was
included in the lipid formulation. COS-7 cells were
incubated with 14C-labeled lipoplexes for 1^4 h.
After the incubation, the cells were treated with Cell-
Scrub bu¡er (PBS-based bu¡er, composition propri-
etary; BIOzymTC BV, The Netherlands) to remove
surface-bound lipoplexes (according to the manufac-
turer’s procedure). The fraction of surface-bound
and the fraction of internalized lipoplexes, de¢ned
as the fraction that was resistant to removal with
CellScrub bu¡er, was counted on a scintillation
counter. In a control experiment performed at 4‡C
(non-permissive temperature for endocytosis) it was
determined that V87% of the COS-7-associated
SAINT/DOPE lipoplexes could be removed with
CellScrub bu¡er. These data imply that less than
13% of the total cell-associated fraction remained
adhered to the cells and/or the culture dish, following
this treatment. Finally, in these experiments, cells
and supernatants were separated by centrifugation
(10 min at 800Ug). At these conditions, pelleting
of lipoplexes did not occur.
2.6. Osmotic rupture of endosomes during transfection
of cells
After 1 and 4 h of incubation with lipoplexes, the
cells were washed and subsequently subjected to an
osmotic shock, using pinocytic cell loading reagent
(Molecular Probes, Eugene, OR, USA), following
essentially a procedure as provided by the manufac-
turer. Brie£y, a hypertonic 1.5 M sucrose solution
was added to the cells for 5 min at 37‡C, followed
by an incubation for 3 min with a hypotonic solution
(cell culture medium diluted with deionized water
(6:4 v/v)). These incubation times were optimized
for the COS-7 cell line, implying that at the incuba-
tion conditions in these bu¡ers signi¢cant cellular
toxicity was not observed. The hypertonic sucrose
solution will induce the formation of pinosomes
that explode in the presence of the hypotonic bu¡er,
releasing their content into the cell’s cytoplasm. Cells
were allowed to recover in cell culture medium for
1 day before transfection e⁄ciency was determined
by FACS analysis.
2.7. Lysosomal staining in COS-7 cells with
LysoTracker Red
COS-7 cells were incubated with N-NBD-PE-la-
beled lipoplex for 1 h. Subsequently, cells were incu-
bated for 15^30 min with 75 pM LysoTracker Red
(Molecular Probes), washed and incubated for 30
min in normal medium to chase the LysoTracker
Red into late endosomal/lysosomal compartments.
Fluoromicrographs were taken with a confocal laser
scanning microscope (Leica TCS SP2; Leica Micro-
systems, Germany), connected to a computer with
Scanware software. Localization of lipoplexes in ly-
sosomal compartments resulted in the colocalization
of both £uorescent labels (green (lipid)+red (Lyso-
Tracker) = orange-yellow).
3. Results
3.1. Serum stabilizes the particle size of SAINT
lipoplexes
To investigate the e¡ects of particle size and stabil-
ity on the interaction of lipoplexes with cells, we
modulated these parameters by the presence of se-
rum. By atomic force microscopy (Fig. 1) it was de-
termined that SAINT-2/DOPE lipoplexes with a mo-
lar charge ratio of V2.5 show an initial size
distribution that varies between 200 and 400 nm.
The round or oval-shaped lipoplexes have a smooth
surface. However, upon incubation at room temper-
ature, extensive aggregation occurs within a few
hours, leading to clustered complexes with sizes
that may exceed 1 Wm (cf. Fig. 5). The addition of
serum to preformed lipoplexes prevents this aggrega-
tion, thereby stabilizing the particle size of the lipo-
plexes. Interestingly, occasionally, we observed ex-
tensions on the surface of the lipoplexes, which
extended towards an adjacent complex (Fig. 1b,
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upper right corner). In principle, serum proteins may
coat the complex or such proteins may, to various
extents, penetrate into the complex, probably gov-
erned by the aggregate structure. To mimic such a
condition, lipoplexes were also prepared in the pres-
ence of serum. These lipoplexes, assembled in serum
([FBS] lipoplexes), did not aggregate over the time
intervals of the experiments and had a size distribu-
tion of 200^250 nm as determined by dynamic light
scattering (data not shown). [FBS] lipoplexes showed
similar tubular extensions, as observed upon exoge-
nous addition of FBS following complex assembly,
though much more abundant. To determine the
stability of these complexes in terms of their size
and ability of providing nucleic acid protection, we
¢rst performed a dextran density gradient centrifuga-
tion of the lipoplexes and investigated their nuclease
accessibility.
3.2. [FBS] lipoplexes show a decrease in size
compared to 3FBS and +FBS lipoplexes
Dextran gradient centrifugation separates particles
on the basis of size and density. Fig. 2 shows that
SAINT-2/DOPE liposomes (I) appear as a distinct
band in the 0% dextran layer. Free DNA (II) appears
as a band on top of the 5% dextran layer with some
di¡use label £oating above the band. Note that for
all the lipoplexes (III^V) the DNA label (EtBr) co-
localizes with the lipid label (N-Rh-PE) (cf. Fig.
Fig. 1. Visualization of lipoplexes by atomic force microscopy (AFM). SAINT-2/DOPE (1:1) lipoplexes were prepared and examined
by AFM as described in Section 2. (a) 3FBS lipoplexes, visualized within 60 min after preparation. The lipoplexes display a smooth
surface, while the size distribution varies between 200 and 400 nm. (b) +FBS lipoplexes were obtained by suspending 3FBS complexes
in serum-containing medium (10% FBS). After 60 min the sample was examined by AFM. Note the occasional presence of tubular ex-
tensions (upper right). (c) [FBS] lipoplexes were prepared by complex assembly in the presence of 10% FBS. After 30 min, the sample
was examined by AFM. Note the extensive appearances of tubular structures extending from the complexes. The extensions originated
from conformational changes of the DNA structure as treatment of (c) with DNase results in the appearance of complexes devoid of
such extensions (d). Bar under (b) also applies to (a). Bar under (d) also applies to (c).
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2A,B), implying that in all lipoplexes the DNA is
complexed by lipids. 3FBS lipoplexes (III) are £oat-
ing on top of the gradient (0% dextran), like lipo-
somes (I), but are heterogeneous in size. +FBS lipo-
plexes (IV) sediment on top of the 10% dextran layer
as one distinct (homogeneous) band. Evidently, the
addition of serum after complex formation (+FBS)
prevents the aggregation (heterogeneous size distri-
bution) of lipoplexes. In addition, the attachment
of serum proteins might enhance the density of
+FBS lipoplexes compared to 3FBS lipoplexes, re-
sulting in a sedimentation of +FBS lipoplexes further
down into the gradient than in the case of 3FBS
lipoplexes. [FBS] lipoplexes equilibrate at an even
higher density than 3FBS and +FBS lipoplexes,
i.e. they sediment at the top of the 15% dextran
Fig. 3. Serum treatment of lipoplexes a¡ects the DNA conformation and enhances nuclease accessibility. Lipoplexes were prepared,
treated with serum as indicated, and the DNA conformation was analyzed by agarose gel electrophoresis, prior and after DNase treat-
ment. Upper panel: Lane 1, 0.5 Wg DNA (stock solution of pEGFP-N1). Lanes 2^4 contain untreated 3FBS, +FBS, and [FBS] lipo-
plexes, respectively. Lanes 5^7 contain DNA released from lipoplexes (3FBS, +FBS, [FBS]), following treatment with Zwittergent.
Lanes 8^10 show the DNA from lipoplexes (3FBS, +FBS, [FBS]), analyzed after their incubation with DNase (1/2 h, 37‡C). The per-
centages of supercoiled (SC) and open-circular (OC) DNA in each sample are indicated. Lower panel : Lane 1, 0.5 Wg DNA; lane 2,
DNA treated with 10% FBS; lane 3, DNA treated with 50% FBS; lane 4, DNA treated with proteinase K, showing no in£uence of
proteinase K on DNA conformation.
Fig. 2. Dextran density gradient of lipoplexes. Lipoplexes were prepared, treated with serum as indicated, and the lipoplex’ size and
density was determined by dextran density gradient centrifugation. I: SAINT-2/DOPE liposomes. II: Free DNA. III: 3FBS lipo-
plexes. IV: +FBS lipoplexes. V: [FBS] lipoplexes. (A) UV-illuminated £uorescence micrograph, showing N-Rh-PE and EtBr (DNA)
£uorescence. (B) Phase contrast picture showing N-Rh-PE. (The upper band that is present at the same level in each gradient is a re-
£ection of the air^water interface (meniscus), an artifact of photography. Dextran gradient centrifugation of lipoplexes prepared in
medium as compared to lipoplexes prepared in HBSS gives similar results.)
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layer, with some lipoplexes remaining in the 10%
dextran layer. The presence of serum during complex
formation ([FBS]) apparently results in the assembly
of lipoplexes that are smaller and/or more dense than
3FBS and +FBS lipoplexes.
3.3. [FBS] lipoplexes show an enhanced nuclease
accessibility compared to 3FBS and +FBS
lipoplexes
At a charge ratio of V2.5 no free DNA is present
in the lipoplex formulation. As can be seen in Fig. 3,
no migration of DNA into the agarose gel occurs.
Incubation of lipoplexes in the presence of serum
(+FBS) or preparation of lipoplexes in the presence
of serum ([FBS]) neither resulted in migration of free
DNA. This implies that the presence of serum does
not prevent the association with or induces the dis-
sociation of plasmid DNA from the cationic lipids
(Fig. 3, upper panel, lanes 2^4). However, the pres-
ence of serum did a¡ect the conformation of DNA in
[FBS] lipoplexes. The DNA topology in these lipo-
plexes is shifted to an open-circular conformation
compared to a predominantly supercoiled conforma-
tion in lipoplexes prepared in the absence of serum.
This is visible after release of DNA from the lipo-
plexes by treatment with a detergent (Fig. 3, upper
panel, lanes 5^7). In 3FBS lipoplexes the DNA is
completely protected from nuclease activity, while in
both +FBS and [FBS] lipoplexes some of the DNA
can be degraded by DNase treatment. After DNase
treatment the conformation of DNA in [FBS] lipo-
plexes is largely open-circular while for 3FBS and
+FBS lipoplexes the major part of the DNA is still
present in a supercoiled conformation. Apparently
[FBS] lipoplexes show the highest nuclease accessibil-
ity, when compared to 3FBS and +FBS lipoplexes
(Fig. 3, upper panel, lanes 8^10). Interestingly, fol-
lowing treatment with DNase, atomic force micros-
copy measurements revealed that the tubular exten-
sion on the [FBS] complexes had essentially
disappeared, and complexes could be seen with sizes
varying between 200 and 300 nm (Fig. 1d).
3.4. Small-sized complexes are internalized by COS-7
cells to a higher extent than large complexes
An incubation of COS-7 cells with 3FBS lipo-
plexes results in a similar amount of total cell asso-
ciation (surface-bound plus internalized) of lipo-
plexes as an incubation with +FBS lipoplexes.
Interestingly, an almost two-fold increase in total
cell association of [FBS] lipoplexes is obtained, com-
pared to the other two types of lipoplexes. In fact,
Fig. 4. Kinetics of total cell association and internalization of
3FBS, +FBS and [FBS] lipoplexes by COS-7 cells. 3FBS lipo-
plexes, +FBS lipoplexes and [FBS] lipoplexes, labeled with a
trace amount of 14C[SAINT-2], were incubated at 37‡C with
COS-7 cells as described in Section 2. After various time inter-
vals, the cells were washed with HBS to remove loosely bound
and non-cell-associated complexes. The cells were subsequently
treated with CellScrub bu¡er (to remove tightly bound cell sur-
face-associated complexes, see Section 2), trypsinized and centri-
fuged. The radioactivity of the supernatant and the cell pellet,
representing surface-bound and internalized lipoplex respec-
tively, was counted in a scintillation counter. The total cell-as-
sociated (radioactivity in supernatant and cell pellet) (a) and
the internalized fraction (b) were plotted as a function of time.
The data were expressed relative to those obtained for the inter-
nalization of 3FBS lipoplexes. The internalization of 3FBS
lipoplex after 4 h of incubation was set as 100%. The experi-
ment was performed twice in duplicate. S.D. þ 10%.
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their internalization after 4 h of incubation is ap-
proximately three-fold higher than that of 3FBS
lipoplexes (Fig. 4).
As shown in Table 1, the presence of serum during
transfection does not in£uence the transfection e⁄-
ciency (i.e. in terms of number of cells transfected) of
SAINT-2/DOPE lipoplexes. Indeed, 3FBS and
+FBS lipoplexes gave essentially the same transfec-
tion e⁄ciencies of COS-7 cells. By contrast, trans-
fection with [FBS] lipoplexes resulted in a 5^10-fold
reduction in e⁄ciency. Thus although the internal-
ization of [FBS] lipoplexes is several-fold higher
than that of 3FBS lipoplexes, the transfection e⁄-
ciency with these lipoplexes is almost an order of
magnitude lower.
3.5. Rapid intracellular processing of [FBS]
lipoplexes to lysosomes
Within 1 h after commencing transfection, [FBS]
lipoplexes show a distinct perinuclear localization in
COS-7 cells. By contrast, after 1 h 3FBS and +FBS
lipoplexes are distributed throughout the cytoplasm
and at the cell periphery. Also note that in the ab-
sence of serum (3FBS), numerous large clustered
particles are attached to the cells. In both cases, a
pronounced perinuclear localization or accumulation
is not observed (Fig. 5). Note that when we em-
ployed rhodamine-labeled plasmid (pGeneGrip, BI-
Ozym, The Netherlands) as a lipoplex marker, in-
stead of the lipid marker N-Rh-PE,
indistinguishable £uorescence distribution patterns
were observed (not shown). However, since the £uo-
rescence resolution was less when applying the la-
beled plasmid, we carried out subsequent work
with rhodamine-labeled lipid as a marker.
COS-7 cells that are incubated with N-NBD-PE-
labeled [FBS] lipoplexes followed by loading with the
lysosomal marker LysoTracker Red, show a perinu-
6
Fig. 5. Distribution of 3FBS, +FBS and [FBS] lipoplexes in
COS-7 cells, as revealed by £uorescence microscopy. COS-7
cells were incubated for 1 h (37‡C) with lipoplexes, labeled with
0.5 mol% N-Rh-PE. Fluorescence microscopy was performed
with an Olympus AX70 microscope equipped with an Olympus
PM-20 photography system. Transfection with 3FBS lipoplexes
(a) results in a heterogeneous distribution of lipoplexes of dif-
ferent sizes, the largest complexes often associating with the cell
periphery. Smaller complexes are found intracellularly, and dif-
fuse £uorescence is often localized throughout the cytoplasm.
Transfection with +FBS lipoplexes (b) results in a far more ho-
mogeneous distribution of lipoplexes that are equal in size, pre-
sumably localizing to endocytic compartments. COS-7 cells, in-
cubated with [FBS] lipoplexes (c) are covered with small
lipoplexes. Intracellularly, the [FBS] lipoplexes show a speci¢c
perinuclear localization.
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Table 1
Transfection e⁄ciency with 3FBS, +FBS, and [FBS] lipoplexes with and without an osmotic shock
Lipoplexes Transfection e⁄ciency (t = 24 h) Transfection e⁄ciency after osmotic shock (t = 24 h) Multiplication factor
3FBS (1 h) 30.5 þ 3.5 36.2 þ 3.4 1.2
+FBS (1 h) 23.8 þ 1.0 42.4 þ 5.5 1.8
[FBS] (1 h) 2.3 þ 0.5 10.9 þ 2.6 5.3
3FBS (4 h) 50.9 þ 6.1 57.1 þ 3.5 1.1
+FBS (4 h) 50.2 þ 5.5 55.3 þ 5.5 1.1
[FBS] (4 h) 11.0 þ 4.9 17.5 þ 3.4 2.0
Values represent means of two experiments in duplicate, expressed as percentage of GFP-positive cells.
Fig. 6. Lysosomal localization of [FBS] lipoplexes. COS-7 cells were incubated for 1 h with N-NBD-PE-labeled (0.5 mol%) lipoplex
(green) followed by a pulse-chase with LysoTracker Red, a lysosomal marker (Molecular Probes). With a confocal microscope two
scans (Vex = 488 nm (green) and Vex = 543 nm (red)) were sequentially run in the plane of the nucleus. The images were merged using
PaintShop Pro computer software. Incubation with [FBS] lipoplexes results in a colocalization (perinuclear) of lipoplex and the Lyso-
Tracker probe (yellow-orange in merged image). Thus [FBS] lipoplexes are located in late endosomes/lysosomes.
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clear colocalization of the lysosomal marker and the
lipoplexes (yellow-orange staining). Thus, these data
indicate that the [FBS] lipoplexes are processed along
the endocytic pathway, leading to their localization
in late endosomal/lysosomal compartments (Fig. 6).
When 3FBS and +FBS lipoplexes were incubated
over a similar time interval (1 h) with COS-7 cells,
little if any overlap of both £uorophores was ob-
served (cf. Fig. 5a,b versus Fig. 5c), implying that
[FBS] complexes are more rapidly processed to a
lysosomal destination than 3FBS and +FBS com-
plexes.
3.6. Osmotic rupture of endosomes early during
transfection enhances the transfection e⁄ciency
with [FBS] lipoplexes
As shown above, the extent of internalization of
lipoplexes by cells does not necessarily correlate with
the transfection e⁄ciency that is achieved with these
lipoplexes. Thus in the presence of serum (+FBS and
[FBS]) the internalization of complex was substan-
tially higher than in the absence of serum, yet the
transfection e⁄ciency was the same or much less.
Interestingly however, treatment of COS-7 cells
with an osmotic shock after relatively short incuba-
tion times (1 h) signi¢cantly increased the transfec-
tion e⁄ciency with +FBS and [FBS] lipoplexes,
whereas a similar treatment of cells transfected with
3FBS lipoplexes was substantially less e¡ective (Ta-
ble 1). For +FBS lipoplexes, the transfection e⁄-
ciency almost doubled after osmotic shock, while
transfection with [FBS] lipoplexes resulted in a
more than ¢ve-fold increase in e⁄ciency, increasing
from less than 3% for the normal transfection pro-
cedure to 10^15% when, following a 1 h incubation,
the cells were subjected to an osmotic shock. After
4 h of incubation, the shock procedure led to a less
pronounced e¡ect in all cases, although in an abso-
lute sense a substantial increase up to about 20%
transfection e⁄ciency is reached in the case of
[FBS] lipoplexes. Most likely, after 4 h of incubation
a considerable amount of the internalized lipoplexes
have reached compartments from which the release is
less e⁄cient after shock treatment than from com-
partments reached early after internalization (1 ver-
sus 4 h).
4. Discussion
The purpose of this work was to de¢ne the pro-
cessing of lipoplexes by cells, using serum as a mod-
ulator of lipoplex size and stability, as serum^lipo-
plex interactions will have obvious implications for
in vivo application. The data provide a rationale for
the discrepancy between lipoplex internalization and
transfection e⁄ciency, the role of particle size/stabil-
ity, and potential e¡ects of serum on lipoplex pro-
cessing and hence transfection e⁄ciency.
In a previous study [14] we demonstrated that an
incubation of lipoplexes prepared from either lipofec-
tin or SAINT-2/DOPE in the presence of serum re-
sulted in the binding of the same proteins to either
complex. Yet, whereas lipofectin-mediated transfec-
tion was strongly inhibited in the presence of serum,
little if any e¡ect was observed when transfecting
cells with SAINT complexes at the same conditions
(cf. Table 1). Apparently, parameters other than sim-
ple steric interference of attached serum proteins
with lipoplex^cell interaction determine the transfec-
tion capacity of a given complex. The present work
strongly suggests that such interfering parameters
may include the ability of serum proteins to pene-
trate into the complex, presumably determined by
its structural integrity and ‘internal’ accessibility,
which in turn is governed by the chemical nature
of the amphiphile.
Clearly, neither the kinetics nor the extent of in-
ternalization represents a limiting step in overall
transfection. On the contrary, both the cell associa-
tion and the internalization of [FBS] lipoplexes is
several-fold higher than that of either 3FBS lipo-
plexes or +FBS lipoplexes. Rather, parameters fol-
lowing complex internalization appear to govern the
e¡ectiveness of subsequent transfection, in particular
the timely release of the plasmid from the complex.
The data (Table 1) indicate that this release is accom-
plished relatively early after internalization. Speci¢-
cally, based upon the observations on the kinetics of
processing of the [FBS] complexes and the strongly
diminished transfection capacity of these complexes,
the results imply that the more rapid the transport
along the endocytic pathway, the slimmer the chan-
ces for productive transfection. Although upon ex-
tended incubation times of lipoplexes the size of
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3FBS and +FBS may di¡er up to several-fold (be-
tween 1 Wm and 200^400 nm, respectively), resulting
in a less e⁄cient internalization of 3FBS complexes
(Fig. 4B), there appears to be a balance between the
rate of intracellular processing along the endocytic
pathway and transfection e⁄ciency, the latter being
likely determined by the e⁄ciency of cytosolic deliv-
ery of the plasmid. Apparently, arrival at the lyso-
somes precludes transfection (Fig. 5, Table 1), as
occurs for [FBS] complexes, implying that factors
that would delay lysosomal delivery and prolong
the residence of lipoplexes in (early) endosomal com-
partments, will favor the e⁄ciency of cellular trans-
fection.
Escape from (early?) endosomal compartments
will be determined by the e⁄ciency of interaction
of the complex with the endosomal membrane from
within, and it is tempting to suggest that the dynam-
ics of the amphiphile to perturb the (endosomal) bi-
layer structure will be instrumental in facilitating the
plasmid’s release. Such a membrane perturbing ca-
pacity of surfactants has been demonstrated before
[21^23], and this feature may in part be related to
their cytotoxic e¡ects. In light of the present results it
is relevant to note that when 3FBS complexes (60
nmol total lipid/4 Wg plasmid) were incubated with
erythrocytes (108 cells), release of hemoglobin, as a
measure of membrane perturbation, occurred, reach-
ing a maximal release of approximately 30% after
15^20 min (not shown). By contrast, less than 5%
release was observed in case of +FBS and [FBS]
complexes, implying a reduced capacity of either
complex to substantially perturb the target (erythro-
cyte) membrane structure. By extrapolation, these
data would thus suggest that the serum-exposed
complexes interact less e⁄ciently with the endosomal
membrane, resulting in a less e⁄cient delivery of
plasmid into the cytosol. Two pieces of evidence in-
dicate however that during intracellular processing
the lipoplexes may well undergo structural changes.
First, +FBS complexes transfect cells as e⁄cient as
3FBS. This would suggest that the potential inhib-
itory e¡ect of attached serum proteins on plasmid
translocation must at least in part be relieved,
when the complex resides in the endosomal compart-
ment. Consistent with such a possibility is the obser-
vation that an osmotic shock, presumably lysing
early endocytic compartments thereby allowing es-
cape of lipoplexes into the cytosol, does result in a
substantial enhancement of productive transfection,
mediated by the serum-exposed complexes (Table 1).
Although we cannot exclude that cytosolic com-
pounds could also play a role in facilitating plasmid
release, which is required for e¡ective transcription
[4,24], the fact that a much less pronounced increase
occurs in case of 3FBS complexes makes this possi-
bility less likely. Thus, these data indicate that after
internalization, the cytoplasmic delivery represents a
signi¢cant barrier for e⁄cient transfection, which ap-
pears to be a¡ected by the relative ease of serum
protein dissociation, determined by the amphiphile
per se and lipoplex structure (e.g. SAINT-2/DOPE
vs. lipofectin, see [14]).
When these proteins acquire subsequently access
within the lipoplex structure, DNA conformational
changes occur and protrusions extend on the com-
plex surface, which further augment transfection in-
hibition, although the mechanism involved appears
quite similar, i.e. interference with lipoplex^endoso-
mal membrane interaction. Simulating such condi-
tions by complex assembly in the presence of FBS,
the results show that the DNA conformation in
[FBS] lipoplexes has to a considerable extent been
converted into an open-circular conformation, com-
pared to a supercoiled structure in 3FBS and +FBS
lipoplexes (Fig. 3). Clearly, as a consequence, the
packing is perturbed leading to surface protrusion
of DNA (Fig. 1), as evidenced by their removal
upon DNase treatment. It is conceivable that the
tubular exposure of the nucleic acid will convey a
negative charge to the lipoplex surface and a struc-
tural, steric hindrance for the cationic lipids to inter-
act with the endosomal membrane. Given in addition
their relatively small size, the particles are then rap-
idly reaching the lysosomes, as re£ected by their peri-
nuclear accumulation and colocalization with lyso-
somal markers (Fig. 6), representing the ¢nal
destination in this degradation pathway.
Finally, since DNA in an open-circular conforma-
tion is transcriptionally less active than supercoiled
DNA [25,26], this feature likely contributes in addi-
tion to the low transfection e⁄ciency that is achieved
with lipoplexes, whose structural properties allow se-
rum penetration.
Taken together, we propose that structural param-
eters of the lipid formulation used for plasmid deliv-
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ery are highly relevant towards the eventual outcome
of transfection e⁄ciency. When less tightly orga-
nized, proteins like those derived from serum could
penetrate into the complexes, leading to DNA con-
formational changes and protein^amphiphile interac-
tions that stabilize the membrane structure, thereby
preventing an e⁄cient early delivery of plasmids into
the cytosol. Relatively small and stabilized particles
may be rapidly processed along the endocytic path-
way and become trapped into lysosomal compart-
ments. Transfection appears to involve an escape
from early compartments, and factors that prolong
their localization in such compartments and favor
e⁄cient interactions between cationic lipid and endo-
somal membrane from within, promote transfection
e⁄ciency.
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